Back to Screener

Technology

Waldencast plc(WALD)

Live Price

Offline

$1.86

+0.00% today

1Y Change

-19.11%

Window

Jun 23, 2025 โ†’ Jun 15, 2026

Market Cap
$100.00M
Revenue Growth
-0.7%
EPS Growth
-415.4%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 23, 2025 โ†’ Jun 15, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Waldencast plc (WALD) is a Technology stock with a market cap of $100.00M and listed on NASDAQ. The stock last traded around $1.86 and down 19.1% across the available one-year price window (Jun 23, 2025 โ†’ Jun 15, 2026). Baseline metrics include revenue growth of -0.7%, EPS growth of -415.4%, a dividend yield of 0.0%. What stands out right now is revenue -0.7%, EPS -415.4%, free cash flow -37.3% with operating margin -22.7% and ROIC -7.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WALD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-0.7% vs +11.9% peer median

Operating Margin

Below sector median

-22.7% vs +22.0% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report came in below the EPS bar

2026 was reported on Mar 13, 2026 with an EPS surprise of -292.3% and a revenue surprise of +113.2%.

The operating picture looks softer than before

Revenue is at -0.7% and EPS is at -415.4%, with operating margin around -22.7%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -4.1% over the next 5 trading days and finished higher after 2 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
Mar 13, 2026
-292.3%-0.6%-25.0%-33.5%
2026
Jan 6, 2026
-20.0%-3.8%+3.8%+17.3%
2025
May 13, 2025
-612.3%+4.9%+8.9%+8.0%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

WALD

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

WALD Max Drawdown

-75.23%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for WALD and SPY.

Calendar-year return history is still loading or unavailable.
Waldencast plc logo

Company Overview

Waldencast plc

NASDAQ Capital Market

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Leadership
Michel Brousset
IPO Date
May 12, 2021
Employees
335
Street Address
10 Bank Street
Mailing
White Plains, NY, 10606
Region
White Plains, NY, US
Reporting Currency
USD
Investor Line
917 546 6828
Last Updated
May 5, 2026
CIK: 0001840199ISIN: JE00BPG99318CUSIP: G9503X103
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
0.4
Price/Book
0.2

Growth

Revenue
-0.7%
EPS
-415.4%
Free Cash Flow
-37.3%

Profitability

Gross Margin
45.5%
Operating Margin
-22.7%
Net Margin
-84.4%
ROE
-47.8%
ROIC
-7.8%

Balance Sheet

Debt/Equity
0.32
Current Ratio
1.70

Earnings Reports

๐Ÿ“… Last reportedMar 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Mar 13, 26
โœ—
-0.51
Est -0.13
-292.3%
139797.0B
Est 65566.3B
+113.2%
โ€”
Jan 6, 26
โœ—
-0.09
Est -0.07
-20.0%
66433.0B
Est 67691.4B
-1.9%
โ€”
May 13, 25
โœ—
-0.28
Est -0.04
-612.3%
142286.0B
Est 71929.3B
+97.8%
โ€”
Nov 20, 24
โœ—
-0.11
Est -0.05
-120.0%
131582.0B
Est 70433.3B
+86.8%
โ€”
May 21, 24
โœ—
-0.64
Est 0.04
-1701.7%
108800.0B
Est 69000.0B
+57.7%
โ€”
Jan 16, 24
โœ—
-0.49
Est -0.01
-7246.3%
89854.0B
Est 59270.0B
+51.6%
โ€”
Jun 29, 23
-0.11
Est โ€”
โ€”
109338.0B
Est 98614.7B
+10.9%
โ€”
Aug 11, 22
โœ—
-0.06
Est 0.01
-700.0%
76279.0B
Est 51550.0B
+48.0%
โ€”
May 16, 22
-0.22
Est โ€”
โ€”
71236.0B
Est โ€”
โ€”
โ€”
Aug 16, 21
-0.22
Est โ€”
โ€”
71236.0B
Est โ€”
โ€”
โ€”
Dec 31, 20
-0.10
Est โ€”
โ€”
47214.0B
Est โ€”
โ€”
โ€”
Jun 30, 20
-0.10
Est โ€”
โ€”
47214.0B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.